SL

Shyam Lal Goel

Active Director Director DIN 07431254
DIN 07431254 First appointment Feb 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2016
Shareholding value •••• Premium profile

About Shyam Lal Goel

Data last updated:

Shyam Lal Goel is a Director at Mrg Biotech Private Limited (since 2016). The company operates in Pharma. Mrg Biotech Private Limited reported revenue of ₹1.65 Cr (FY 2019).

DIN 07431254
Primary Designation Director
Industry Pharma
First Appointment 08 Feb 2016
Oldest Company Age 14 yrs
Largest company Mrg Biotech Private Limited · ₹1.65 Cr (FY 2019)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mrg Biotech Private Limited U51900HR2012PTC045223
Director08 Feb 20162012₹1.65 Cr (FY 2019)Active

Board colleagues of Shyam Lal Goel

NameDINCompanyDesignation
Pawan Goel05183729Mrg Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Mrg Biotech Private Limited
Premium access

Shareholding and investment profile for Shyam Lal Goel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shyam Lal Goel

Shyam Lal Goel currently holds 1 directorship: Mrg Biotech Private Limited (Director, since 08 Feb 2016, revenue ₹1.65 Cr (FY 2019)).

Shyam Lal Goel was first appointed on 08 Feb 2016 as Director at Mrg Biotech Private Limited.

The current boards of Shyam Lal Goel's companies include Pawan Goel (Mrg Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available